Case Filed In CMM Court Infake Covid Medicines’ Case

Kanpur : Gangs which supplied fake medicines during the Covid second wave in Uttar Pradesh and Uttarakhand had been busted by the crime branch of UP Police last year. Now the lab reports have also confirmed that the medicines sold by such gangs were fake. Most of the drugs were antibiotics and pain relievers. The drug department had sent the samples for laboratory tests.

After sending the report to the government and the Kanpur district magistrate on behalf of the drugs department, a case was filed in the CMM court here on March 31.

To recall, the STF had arrested several people and seized 268 fake Remdesivir injections in Babupurwa locality of the city. After this the crime branch became active and the team led by the then ADCP Deepak Bhukar raided Uttarakhand and several cities, including Kanpur, Lucknow, Meerut, Aligarh and Hapur. During this period, there was a huge seizure of medicines, besides raw material for making medicines, packing machines, wrappers, etc. The drug department had sent the samples of these drugs to the laboratory for testing. Now after the investigation report, it came to fore that all these medicines were fake.

The drugs department filed a case on March 31 in the local Chief Metropolitan Magistrate (CMM) court after the medicines were found to be counterfeit.

“A case has been filed in connection with seizure of fake medicines during the second wave of Covid last year. Also, a final report with regard to its investigation has also been attached. An owner of a medicines warehouse- Manish, a resident of Lucknow (Ashiyana), was among those arrested. He used to produce and supply spurious medicines in the market along with his associates on a large scale,” said drug inspector Sandesh Kumar Maurya.

  • Related Posts

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    In a landmark ruling that will have far-reaching implications for the pharmaceutical sector, the High Court of Himachal Pradesh has quashed three criminal complaints filed by the Central Drugs Standard…

    Eli Lilly launches cancer drug Tanstrive in India

    New Delhi: Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from the Central Drugs Standard Control Organisation…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    HP HC quashes CDSCO complaints against pharma firms over jurisdictional and procedural lapses

    Eli Lilly launches cancer drug Tanstrive in India

    Eli Lilly launches cancer drug Tanstrive in India

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Sir Ganga Ram Hospital excels in Medical Research among Private Hospitals

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    Centre eases BIS quality compliance with new risk-based framework for manufacturers

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    SS Innovations International aces Race beating Global Giants in Surgical Robotics

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility

    ‘SHE’ comes all the Way from Calcutta to Delhi to Care for Women’s Fertility